Vivoryon Therapeutics N.V. (0R3M.L) LSE

1.64

+0.02(+1.23%)

Updated at September 29 08:01AM

Currency In EUR

Valuation

Market Cap51.81M
Enterprise Value42.55M
P/E Ratio-2.05
PEG Ratio-0.06
Price/Sales Ratio0
Price/Book Ratio5.36
Enterprise/Revenue0
Enterprise/EBITDA-1.61

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterDecember 31, 2024

Profitability

Profit Margin0
Operating Margin0

Management Effectiveness

Return On Assets-1.82
Return On Equity-1.88

Income Statement

Revenue0
Revenue/Share0
Gross Profit-147,000
EBITDA-20.34M
Net Income-20.57M
Diluted EPS-0.79

Balance Sheet

Total Cash9.37M
Total Cash/Share0.36
Total Debt102,000
Total Debt/Equity0.01
Current Ratio7.2
Book Value Per Share0.3

Price History

52-Week Change-44.59
52-Week High19.4
52-Week Low0.5
Moving Average 50 Days7.3
Moving Average 200 Days9.93

Statistics

Average Volume3,012
Shares Outstanding26.29M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor256:251
Last Split DateOctober 24, 2019